Latest Stories

Don’t miss our hot and upcoming stories
Could Pfizer and BioNTech’s LP.8.1-Adapted COMIRNATY® Redefine COVID-19 Protection for High-Risk Adults in 2025-2026?

Key Insights: Robust Phase 3 Findings for High-Risk PopulationsThe topline results from the Phase 3…

ByByAnuja Singh Sep 11, 2025
Will Merck’s CAPVAXIVE® 21-Valent Vaccine Set a New Benchmark in Pediatric Pneumococcal Protection After Phase 3 Success?

Key Highlights Promising Phase 3 Data from STRIDE-13 TrialMerck announced that CAPVAXIVE demonstrated robust immunogenicity…

ByByAnuja Singh Sep 11, 2025
Could Sanofi’s One-Time Gene Therapy SAR402663 Transform Treatment for Neovascular Age-Related Macular Degeneration?

Key Highlights A Major Step Forward in Retinal Disease InnovationThe FDA’s Fast Track designation underscores…

ByByAnuja Singh Sep 11, 2025
Is Lilly’s “TuneLab” the Breakthrough AI Collaboration Model Biotech Startups Have Been Waiting For?

Key Highlights A bold move: Lilly democratizes AI for biotechEli Lilly has launched TuneLab, a…

ByByAnuja Singh Sep 10, 2025
Scroll to Top